Citicoline Benefits: What the Evidence Really Shows

Citicoline is a compound the body uses to build cell membranes and to synthesise acetylcholine, a neurotransmitter linked to memory and attention. Those are precisely the most studied benefits — cognition, memory and attention — but the evidence is uneven: there are positive results in people with cognitive decline, in patients after a stroke and in healthy adolescents, yet the overall quality of the studies is weak and there is no official recommended dose. In short: it is promising, not definitive, and it does not replace sleep, food and exercise.

This page explains what citicoline is, what the studies actually measured, in which populations, at which doses and with which limitations — and what that means for anyone thinking of trying it.

What is citicoline and what does it do in the body?

Citicoline, also called CDP-choline (cytidine-5'-diphosphocholine), is an endogenous compound — that is, it occurs naturally in the body. When you take it, it is hydrolysed and dephosphorylated into cytidine and choline, which re-form CDP-choline inside brain cells ¹. There it takes part in the synthesis of cell membrane phospholipids, especially phosphatidylcholine, and contributes to neurotransmitter levels in the central nervous system ¹.

In animal models of cerebral ischaemia, citicoline raised glutathione levels and reduced arachidonic acid release and the loss of phosphatidylcholine, cardiolipin and sphingomyelin — proposed mechanisms for a possible membrane-stabilising effect ². That is biology, not proof of clinical benefit in healthy people.

Citicoline benefits: what the evidence says

The strongest evidence does not come from healthy adults who want to "perform better", but from specific clinical populations. It is worth separating the contexts, because mixing them leads to wrong conclusions.

Cognitive decline and dementia

A systematic review with meta-analysis selected seven studies in people with mild cognitive decline, Alzheimer's disease or post-stroke dementia, published between 2010 and 2022. All showed a positive effect of citicoline on cognitive functions and, in the meta-analysis of six studies, cognitive status improved, with standardised mean differences between 0.56 (95% CI: 0.37–0.75) and 1.57 (95% CI: 0.77–2.37) across the different sensitivity analyses — but the authors rated the overall quality of the studies as weak ³.

A broader systematic review, which looked at 47 articles on citicoline in neurological diseases, suggested the compound may have a role in slowing the progression of dementia and in improving cognitive functions, including in healthy individuals, and that it may improve prognosis after stroke, although the quality of the evidence is limited ⁴.

Attention and psychomotor speed in healthy people

The most cited trial in this area involved 75 healthy male adolescents, randomised to citicoline (250 or 500 mg) or placebo for 28 days. Those who received citicoline showed better attention (p = 0.02) and greater psychomotor speed (p = 0.03) than placebo; higher weight-adjusted doses predicted greater accuracy on an attention task (p = 0.01) and lower impulsivity (p = 0.01) ⁵. It is a small trial, in a very specific population — adolescents — and should not be extrapolated to adults as if it were proof of general efficacy.

Stroke: where the evidence is strongest

Citicoline has been studied as a treatment for acute ischaemic stroke. A meta-analysis of ten randomised, double-blind, placebo-controlled clinical trials found a significantly higher rate of independence with citicoline (OR 1.56; 95% CI: 1.12–2.16 in the random-effects model), with a more evident effect in the subgroup of patients not treated with rtPA ⁶. An earlier review, with more than 11,000 patients studied across various neurological conditions, concluded that citicoline is safe and may have a beneficial effect in acute ischaemic stroke, especially in less severe strokes and in older patients ⁷.

This is a hospital clinical context, with patients and often with intravenous or intramuscular administration — not the same as taking a gummy at home.

Eye and optic nerve

In glaucoma, a 2023 systematic review concluded that conclusive evidence on the effect of citicoline on disease progression is lacking ⁸. An earlier review described neuroprotective effects in animal models and in neurodegenerative diseases of the retina, with reduced impairment of ganglion cells after citicoline administration ⁹. These are areas of research, not supplement indications.

Doses used in studies and what the gummy label says

The doses investigated vary widely with the goal and the population: 250 or 500 mg per day in the trial in healthy adolescents over 28 days ⁵; 100 mg three times a day (300 mg/day) for three months in a trial in people with vascular cognitive impairment without dementia ¹⁰; and 1,000 mg per day intramuscularly in patients with Parkinson's, in a 24-week trial ¹¹.

Study doses are not dosing instructions. For comparison with what is available in the TuttiBear range: the Focus and Concentration Gummies provide 100 mg of citicoline per 2-gummy serving, in a 60-gummy jar, with directions to chew 2 gummies per day, preferably after a meal. That is a lower dose than most of the trials cited — which is relevant for calibrating expectations.

Context	Population	Dose studied	Duration
Attention and psychomotor speed 5	75 healthy adolescents	250 or 500 mg/day	28 days
Vascular cognitive impairment without dementia 10	216 adults, mean age 65.4 years	100 mg three times/day	3 months
Parkinson's (adjunct) 11	474 randomised patients	1,000 mg/day intramuscular	24 weeks
Focus and Concentration Gummies (label)	Adults	100 mg per 2 gummies	—

Who may consider it and who should be cautious

Citicoline is generally well tolerated in the available studies, including in clinical populations ⁷. Even so, there are groups for whom caution is essential.

• Adults with memory complaints or periods of high mental demand: this is the profile closest to what has been studied, although with modest results and weak study quality ³.
• Pregnant or breastfeeding women and children: the product warnings state that it is not intended for children and is not recommended for pregnant or breastfeeding women. In these cases, talk to a healthcare professional before considering any supplement.

In addition, citicoline may cause mild side effects in some people, such as headaches, insomnia or gastrointestinal discomfort, although these are rare. If you notice any of these symptoms, stop taking it and talk to a healthcare professional.

• People with a diagnosed condition or taking medication: citicoline does not replace treatment. If you have a condition or take medicines, consult a healthcare professional before consuming it.

Citicoline in gummy form: what changes (and what does not)

There are no studies directly comparing citicoline gummies with tablets or capsules. What is known is that ingested citicoline is hydrolysed and dephosphorylated to form cytidine and choline, which re-synthesise CDP-choline inside brain cells ¹ — a process that depends on the compound absorbed, not on the pharmaceutical form itself. The form may influence adherence (chewing two gummies is easier for those who dislike swallowing capsules), but there are no data showing superiority of one form over another. To go deeper, see citicoline gummies or tablets.

When to take it and what to expect

There is no time of day established by research. In the trials, dosing was distributed in different ways: once a day ⁵, three times a day ¹⁰ or in intramuscular cycles ¹¹. The product directions suggest chewing 2 gummies per day, preferably after a meal. If you notice a stimulating effect, avoid taking it late in the day. For more details, see citicoline: when to take it.

If you decide to try it, start with a low dose and observe how you feel. Consistency matters more than the exact time.

As for timing: trials with cognitive outcomes used durations of 28 days to 3 months ⁵¹⁰. There is no basis for expecting results in days, and there is also no guarantee that you will notice them.

If you notice no difference after 4 to 6 weeks, it may not be the right supplement for you.

What citicoline does not do

It is important to be clear: citicoline does not prevent, treat or cure diseases, including dementia or Alzheimer's. Studies in dementia show positive effects on cognitive tests, but with weak methodological quality ³, and citicoline in the context of stroke is a clinical treatment with medical supervision, not a routine supplement ⁶.

It is also not a stimulant and does not replace the pillars of cognitive health: quality sleep, regular physical activity, a varied diet and mental stimulation. No supplement compensates for badly slept nights.

Where vitamin B12 and B6 fit into the gummies

Besides citicoline, the Focus and Concentration Gummies include 500 µg of vitamin B12 (methylcobalamin) and 1.4 mg of vitamin B6 (pyridoxine) per 2-gummy serving. Vitamin B12 and vitamin B6 contribute to the normal functioning of the nervous system ¹². This is the claim authorised under Regulation (EU) No 432/2012 and should not be read as a promise of a cognitive effect.

If you are looking for options in the same area, you can explore the Energy and Focus collection or see all the citicoline gummies in the range.

Limitations of the evidence, in summary

• The overall quality of studies in cognition is weak and the samples are small ³.
• Trials in healthy people are few and focus on specific populations, such as male adolescents ⁵.
• In glaucoma, conclusive evidence is lacking ⁸.
• There are no studies comparing pharmaceutical forms (gummy vs. tablet).
• There is no official recommended dose and no established half-life for supplement use.

In summary: citicoline has a clear biological basis and interesting results in clinical contexts and in some studies with healthy people, but the evidence is emerging and does not allow promises. If you decide to try it, do so with realistic expectations, respecting the label, and talk to a healthcare professional if you have any condition or take medication.

Frequently asked questions

Is citicoline safe for daily use?

In the available studies, including clinical populations, citicoline was considered safe and well tolerated. Even so, data on long-term use in healthy people are limited. If you are pregnant, breastfeeding, have a condition or take medication, talk to a healthcare professional before consuming it.

How long does citicoline take to work?

Trials with cognitive outcomes used durations of between 28 days and 3 months. There is no basis for expecting results in a few days, and there is also no guarantee that you will notice differences. If you notice nothing after a few weeks, it is possible that it is not the right supplement for you.

What is the difference between citicoline and choline?

Citicoline is a form of choline with its own structure (CDP-choline). When ingested, it is broken down into cytidine and choline, which re-form CDP-choline inside brain cells, taking part in the synthesis of membrane phospholipids and in neurotransmitter levels. Plain choline is a different and cheaper raw material.

Can I take citicoline with coffee?

There are no known interactions described in the reviewed studies. However, if you are sensitive to caffeine, you may feel more activated, since citicoline takes part in the synthesis of acetylcholine, a neurotransmitter linked to attention. Start with the dose stated on the label and observe how you feel.

Is citicoline suitable for children or adolescents?

TuttiBear gummies are not intended for children and should not be consumed by minors. There is one trial in healthy male adolescents, but that does not amount to a recommendation for use in this age group. For any supplement in children or adolescents, advice from a healthcare professional is needed.

Does citicoline replace treatment for diseases such as Alzheimer's or Parkinson's?

No. Citicoline does not prevent, treat or cure diseases. Studies in dementia show positive effects on cognitive tests, but with weak methodological quality, and its use in stroke or Parkinson's is in a clinical context and under medical supervision. Never replace a prescribed treatment with a supplement.